Corcept Therapeutics (CORT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

CORT Events is the leading provider of furniture rental in the continental United States. Trust us to provide value and deliver style and service 24/7/365. We have the skills and the knowledge to ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). CORT, ZBRA and QUAD made it to the Zacks Rank ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Corcept Therapeutics (CORT – Research Report). The company’s shares closed last Friday at $47.62.

Truist Financial analyst Joon Lee maintained a Buy rating on Corcept Therapeutics (CORT – Research Report) today. The company’s shares closed last Friday at $49.75. According to TipRanks ...

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has received an average recommendation of “Buy” from the five brokerages that are covering the company, MarketBeat reports.